Skin disorders in Ashkenazi Jews: A review

International Journal of Dermatology

Volumn 44, Issue 8, 2005, Pages 630-635

  Barankin, Benjamin ^a,b   Metelitsa, Andrei I ^a   Schloss, Eric H ^a   Wasel, Norman R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University Dermatology Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HLA A ANTIGEN; HYDROCORTISONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; STEROID 21 MONOOXYGENASE;

BLOOM SYNDROME; CANCER PREVENTION; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CROHN DISEASE; DYSAUTONOMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FOUNDER EFFECT; GENE MUTATION; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; INCIDENCE; JEW; KAPOSI SARCOMA; MELANOMA; MORTALITY; PATHOGENESIS; PEMPHIGUS VULGARIS; PENIS CARCINOMA; PREVALENCE; RELIGION; REVIEW; SKIN DISEASE; SUN EXPOSURE;

HUMANS; INCIDENCE; JEWS; SKIN DISEASES;

EID: 23844444950     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02625.x     Document Type: Review

References (74)

1. Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin 2003; 21: 601-607.
2. Taylor SC. Epidemiology of skin diseases in people of color. Cutis 2003; 71: 271-275.
3. Cornelison RL Jr. Cutaneous diseases in Native Americans. Dermatol Clin 2003; 21: 699-702.
4. Bang D. Clinical spectrum of Behcet's disease. J Dermatol 2001; 28: 610-613.
5. Scully C, Challacombe SJ. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management. Crit Rev Oral Biol Med 2002; 13: 397-408.
6. Buonaguro FM, Tomesello ML, Buonaguro L, et al. Kaposi's sarcoma: aetiopathogenesis, histology and clinical features. J Eur Acad Dermatol Venereol 2003; 17: 138-154.
7. Penagos H, Jaen M, Sancho MT, et al. Kindler syndrome in native Americans from Panama: report of 26 cases. Arch Dermatol 2004; 140: 939-944.
8. Goodman RM. Genetic Disorders Among the Jewish People. Baltimore: The Johns Hopkins University Press, 1979.
9. Zinberg RE, Kornreich R, Edelmann L, et al. Prenatal genetic screening in the Ashkenazi Jewish population. Clin Perinatol 2001; 28: 367-382.
10. Bloom D. Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs. Am J Dis Child 1954; 88: 754-758.
11. German J. Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients. Am J Hum Genet 1969; 21: 196-227.
12. German J, Bloom D, Passarge E, et al. Bloom's syndrome. VI. The disorder in Israel and an estimation of the gene frequency in the Ashkenazim. Am J Hum Genet 1977; 29: 553-562.
13. Ellis NA, Ciocci S, Proytcheva M, et al. The Ashkenazic Jewish Bloom syndrome mutation blmAsh is present in non-Jewish Americans of Spanish ancestry. Am J Hum Genet 1998; 63: 1685-1693.
14. German J. Bloom's syndrome. Dermatol Clin 1995; 13: 7-18.
15. Abel EL. Jewish Genetic Disorders: a Layman's Guide. Jefferson: McFarland & Company, 2001.
16. Champion RH, Burton JL, Burns DA, et al. Rook/Wilkinson/Ebling Textbook of Dermatology. Oxford: Blackwell Science, 1998.
17. Roa BB, Savino CV, Richards CS. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation. Genet Test 1999; 3: 219-221.
18. Gretzula JC, Hevia O, Weber PJ. Bloom's syndrome. J Am Acad Dermatol 1987; 17: 479-488.
19. Shahrabani-Gargir L, Shomrat R, Yaron Y, et al. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin. Genet Test 1998; 2: 293-296.
20. Mayr E. Systematics and the Origin of Species. New York: Columbia University Press, 1942.
21. Ellis NA, Roe AM, Kozloski J, et al. Linkage disequilibrium between the FES, D15S127, and BLM loci in Ashkenazi Jews with Bloom syndrome. Am J Hum Genet 1994; 55: 453-460.
22. Li L, Eng C, Desnick RJ, et al. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population. Mol Genet Metab 1998; 64: 286-290.
23. Oddoux C, Clayton CM, Nelson HR, et al. Prevalence of Bloom syndrome heterozygotes among Ashkenazi Jews. Am J Hum Genet 1999; 64: 1241-1243.
24. Ahmed AR, Yunis EJ, Alper CA. Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patients. Hum Immunol 1990; 27: 298-304.
25. Pisanti S, Sharav Y, Kaufman E, et al. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 1974; 38: 382-387.
26. Korman NJ. Pemphigus. Dermatol Clin 1990; 8: 689-700.
27. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996; 34: 645-652.
28. Krain LS, Terasaki PI, Newcomer VD, et al. Increased frequency of HL-A10 in pemphigus vulgaris. Arch Dermatol 1973; 108: 803-805.
29. David M, Zamir R, Segal R, et al. HLA antigens in Jews with pemphigus vulgaris. Dermatologica 1981; 163: 326-330.
30. Ahmed AR, Park MS, Tiwari JL, et al. Association of DR4 with pemphigus. Exp Clin Immunogenet 1987; 4: 8-16.
31. Ahmed AR, Yunis EJ, Khatri K, et al. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1990; 87: 7658-7662.
32. Mobini N, Yunis EJ, Alper CA, et al. Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin. Hum Immunol 1997; 57: 62-67.
33. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph 1872; 4: 265-273.
34. Zidan J, Robenstein W, Abzah A, et al. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease. Isr Med Assoc J 2001; 3: 251-253.
35. Wahman A, Melnick SL, Rhame FS, et al. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma. Epidemiol Rev 1991; 13: 178-199.
36. Ross RK, Casagrande JT, Dworsky RL, et al. Kaposi's sarcoma in Los Angeles, California. J Natl Cancer Inst 1985; 75: 1011-1015.
37. Fenig E, Brenner B, Rakowsky E, et al. Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol 1998; 21: 498-500.
38. Brenner B, Weissmann-Brenner A, Rakowsky E, et al. Classical Kaposi sarcoma: prognostic factor analysis of 248 patients. Cancer 2002; 95: 1982-1987.
39. Iscovich J, Boffetta P, Brennan P. Classic Kaposi's sarcoma in Arabs living in Israel, 1970-93: a population-based incidence study. Int J Cancer 1998; 77: 319-321.
40. Iscovich J, Boffetta P, Franceschi S, et al. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 2000; 88: 500-517.
41. Iscovich J, Boffetta P, Winkelmann R, et al. Classic Kaposi's sarcoma in Jews living in Israel, 1961-89: a population-based incidence study. AIDS 1998; 12: 2067-2072.
42. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. J Am Med Assoc 1932; 99: 1323-1329.
43. Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol 1999; 94: 2961-2965.
44. Roth MP, Petersen GM, McElree C, et al. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 1989; 96: 1016-1020.
45. Odes HS, Locker C, Neumann L, et al. Epidemiology of Crohn's disease in southern Israel. Am J Gastroenterol 1994; 89: 1859-1862.
46. Fidder HH, Avidan B, Lahav M, et al. Clinical and demographic characterization of Jewish Crohn's disease patients in Israel. J Clin Gastroenterol 2003; 36: 8-12.
47. Burgdorf W. Cutaneous manifestations of Crohn's disease. J Am Acad Dermatol 1981; 5: 689-695.
48. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55: 401-412.
49. Riley CM, Day RL, Greeley DM, et al. Central autonomic dysfunction with defective lacrimation: report of five cases. Pediatrics 1949; 3: 468-478.
50. Maayan C, Kaplan E, Shachar S, et al. Incidence of familial dysautonomia in Israel 1977-81. Clin Genet 1987; 32: 106-108.
51. Brunt PW, McKusick VA. Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature. Medicine (Baltimore) 1970; 49: 343-374.
52. Slaugenhaupt SA, Blumenfeld A, Gill SP, et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001; 68: 598-605.
53. Anderson SL, Coli R, Daly IW, et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 2001; 68: 753-758.
54. Gadoth N, Margalith D, Schlien N, et al. Presence of fungiform papillae in classic dysautonomia. Johns Hopkins Med J 1982; 151: 298-301.
55. Mass E, Sarnat H, Ram D, et al. Dental and oral findings in patients with familial dysautonomia. Oral Surg Oral Med Oral Pathol 1992; 74: 305-311.
56. New MI. Genetic disorders of adrenal hormone synthesis. Horm Res 1992; 37: 22-33.
57. Cutler GB Jr, Laue L. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1990; 323: 1806-1813.
58. Meiner V, Landsberger D, Berkman N, et al. A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews. Am J Hum Genet 1991; 49: 443-449.
59. Brown MS, Goldstein JL. The hyperlipoproteinemias and other disorders of lipid metabolism. In: Isselbacher KJ, Braunwald E, Wilson JD, et al., eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1994: 2064-2066.
60. Durst R, Colombo R, Shpitzen S, et al. Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews. Am J Hum Genet 2001; 68: 1172-1188.
61. Gilead L, Vardy DA, Schamroth J. Tefillin dermatitis (a phylacteric phenomenon). J Am Acad Dermatol 1995; 32: 812-813.
62. Naimer SA, Trattner A, Biton A, et al. Davener's dermatosis: a variant of friction hypermelanosis. J Am Acad Dermatol 2000; 42: 442-445.
63. Abanmi AA, Al Zouman AY, Al Hussaini H, et al. Prayer marks. Int J Dermatol 2002; 41: 411-414.
64. Shoufani A, Golan J. Shabbes burn, a burn that occurs solely among Jewish orthodox children; due to accidental shower from overhead water heaters. Burns 2003; 29: 61-64.
65. Gesundheit B, Grisaru-Soen G, Greenberg D, et al. Neonatal genital herpes simplex virus type 1 infection after Jewish ritual circumcision: modern medicine and religious tradition. Pediatrics 2004; 114: e259-e263.
66. Vardi G, Modan B, Golan R, et al. Orthodox Jews have a lower incidence of malignant melanoma. A note on the potentially protective role of traditional clothing. Int J Cancer 1993; 53: 771-773.
67. Micali G, Nasca MR, Innocenzi D, et al. Invasive penile carcinoma: a review. Dermatol Surg 2004; 30: 311-320.
68. Matalon R, Matalon KM. Canavan disease, prenatal diagnosis and genetic counseling. Obstet Gynecol Clin North Am 2002; 29: 297-304.
69. Karban A, Waterman M, Panhuysen CI, et al. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Am J Gastroenterol 2004; 99: 1134-1140.
70. Vallance H, Ford J. Carrier testing for autosomal-recessive disorders. Crit Rev Clin Lab Sci 2003; 40: 473-497.
71. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol 2004; 104: 425-428.
72. Seftel HC, Baker SG, Jenkins T, et al. Prevalence of familial hypercholesterolemia in Johannesburg Jews. Am J Med Genet 1989; 34: 545-547.
73. Strom CM, Crossley B, Redman JB, et al. Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory. Genet Med 2004; 6: 145-152.
74. Ross B, Brancaccio RR. Allergic contact dermatitis to religious articles. Am J Contact Dermatitis 1994; 5: 160-161.